Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

PharmaCyte Biotech submits Drug Master File to USFDA for Pancreatic Cancer Therapy

Ruchika Sharma2 Aug 2020 9:00 AM IST

Laguna Hills: PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer and diabetes using its...

CDSCO panel recommends Serum Institute of India for phase 2, 3 human clinical trials of Oxford vaccine candidate

Ruchika Sharma1 Aug 2020 11:55 AM IST

New Delhi: A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute...

Tata Capital Growth Fund to invest Rs 225 crore in Biocon Biologics

Ruchika Sharma1 Aug 2020 11:42 AM IST

Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.

Advent International to acquire 60 percent stake in RA Chem Pharma

Ruchika Sharma1 Aug 2020 9:30 AM IST

They also said the PE Firm is acquiring up to 60 per cent stake in the pharmaceutical company.

Johnson and Johnson begins human safety trial for its COVID-19 vaccine candidate

Ruchika Sharma1 Aug 2020 9:15 AM IST

US: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Torrent Pharma shares surge 13 per cent after Q1 earnings

Ruchika Sharma1 Aug 2020 9:00 AM IST

New Delhi: Shares of Torrent Pharmaceuticals rallied 13 per cent on Friday after the company reported a 48.61 per cent rise in its consolidated net...

AstraZeneca reports strong drug sales in Q2 amid lockdown

Ruchika Sharma31 July 2020 2:13 PM IST

Newer drugs for diabetes, heart conditions and cancer, including its top selling lung cancer drug Tagrisso, performed well in the quarter and...

Lincoln Pharma to begin API production at Khatraj plant in 1-2 years

COVID-19: Lincoln Pharma introduces immunity-boosting Vitamin C+Zinc Tablets

Ruchika Sharma31 July 2020 12:40 PM IST

Gujarat: Lincoln Pharmaceuticals Limited has announced that it has launched Chewable Vitamin C + Zinc Tablet for the markets in...

Dr Reddys Labs PAT down by 13 percent to Rs 579.3 crore, gears up to launch 2 COVID drugs next month

Ruchika Sharma31 July 2020 12:04 PM IST

The company has geared up to launch two anti-viral drugs Remdesivir and Favipiravir - for the treatment of COVID-19 next month.

Boston Scientific Corp releases quarterly results, says elective surgery recover in July

Ruchika Sharma31 July 2020 9:15 AM IST

US: Medical device maker Boston Scientific Corp on Wednesday posted a surprise adjusted quarterly profit and said demand for elective procedures...

Merck HIF-2α Inhibitor MK-6482 gets Breakthrough Therapy Designation from USFDA

Ruchika Sharma31 July 2020 9:00 AM IST

Kenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has granted...

DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

Ruchika Sharma30 July 2020 3:11 PM IST

New Delhi: A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the Drugs Controller General of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok